Cargando…

Next-generation sequencing in chronic lymphocytic leukemia: recent findings and new horizons

The rapid progress in next-generation sequencing technologies has significantly contributed to our knowledge of the genetic events associated with the development, progression and treatment resistance of chronic lymphocytic leukemia patients. Together with the discovery of new driver mutations, next...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Vicente, Ana E., Bikos, Vasilis, Hernández-Sánchez, María, Malcikova, Jitka, Hernández-Rivas, Jesús-María, Pospisilova, Sarka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642634/ https://www.ncbi.nlm.nih.gov/pubmed/29050359 http://dx.doi.org/10.18632/oncotarget.19525

Ejemplares similares

Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damage
por: Mancikova, Veronika, et al.
Publicado: (2022)

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
por: Lobello, Cosimo, et al.
Publicado: (2018)

Identification of novel sequence variations in microRNAs in chronic lymphocytic leukemia
por: Kminkova, Jana, et al.
Publicado: (2014)

Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study
por: Sutton, Lesley-Ann, et al.
Publicado: (2020)

Next-generation sequencing and FISH studies reveal the appearance of gene mutations and chromosomal abnormalities in hematopoietic progenitors in chronic lymphocytic leukemia
por: Quijada-Álamo, Miguel, et al.
Publicado: (2017)

ToTem: a tool for variant calling pipeline optimization
por: Tom, Nikola, et al.
Publicado: (2018)

The Evolving Landscape of Chronic Lymphocytic Leukemia on Diagnosis, Prognosis and Treatment
por: Pérez-Carretero, Claudia, et al.
Publicado: (2021)

Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
por: Taus, Petr, et al.
Publicado: (2021)

P602: SINGLE-CELL RNA-SEQUENCING ENABLES TRACKING AND CHARACTERIZATION OF RARE CLL CELLS WITH THE POTENTIAL TO CAUSE REFRACTORINESS.
por: Kurucová, Terézia, et al.
Publicado: (2023)

Journey to the next horizon
por: Kong, Yoon
Publicado: (2023)

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
por: Campo, Elias, et al.
Publicado: (2018)

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
por: Quijada‐Álamo, Miguel, et al.
Publicado: (2021)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia
por: Visentin, Andrea, et al.
Publicado: (2020)

NEMHESYS—European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics
por: Serramito-Gómez, Inmaculada, et al.
Publicado: (2021)

CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
por: Hernández-Sánchez, María, et al.
Publicado: (2018)

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
por: Malcikova, J, et al.
Publicado: (2015)

Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
por: Rigolin, Gian Matteo, et al.
Publicado: (2016)

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
por: Banales, Jesus M., et al.
Publicado: (2020)

Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
por: Davi, Frédéric, et al.
Publicado: (2020)

Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression
por: Quijada-Álamo, Miguel, et al.
Publicado: (2021)

Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL
por: Brazdilova, K, et al.
Publicado: (2018)

Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations
por: Rigolin, Gian Matteo, et al.
Publicado: (2016)

Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
por: Olbertova, Helena, et al.
Publicado: (2022)

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation
por: Malcikova, J., et al.
Publicado: (2018)

Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia
por: Plešingerová, Hana, et al.
Publicado: (2018)

From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct
por: González-Gascón-y-Marín, Isabel, et al.
Publicado: (2021)

Restoration of the immune function as a complementary strategy to treat Chronic Lymphocytic Leukemia effectively
por: Moreno, Carol, et al.
Publicado: (2021)

Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing
por: Gupta, Sanjeev Kumar, et al.
Publicado: (2020)

Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
por: Simon, Florian, et al.
Publicado: (2023)

Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
por: Mancikova, Veronika, et al.
Publicado: (2020)

Opinion: What defines high-risk CLL in the post-chemoimmunotherapy era?
por: Edelmann, Jennifer, et al.
Publicado: (2023)

Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia
por: Polychronidou, Eleftheria, et al.
Publicado: (2018)

Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
por: Malcikova, Jitka, et al.
Publicado: (2021)

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index
por: Muñoz-Novas, Carolina, et al.
Publicado: (2018)

DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy
por: Tsagiopoulou, Maria, et al.
Publicado: (2019)

Overview of recent developments in chronic lymphocytic leukemia
por: Jain, Preetesh, et al.
Publicado: (2012)

Recent therapeutic advances in chronic lymphocytic leukemia
por: Bose, Prithviraj, et al.
Publicado: (2017)

Recent advances in chronic lymphocytic leukemia therapy
por: Uhm, Jieun
Publicado: (2020)

Molecular Characterization of Chronic Lymphocytic Leukemia Patients with a High Number of Losses in 13q14
por: Rodríguez, Ana Eugenia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_q86e38lncfdtc1u9fg0vh84bs2